Yang Dajun

Yang Dajun is listed in filings as Chairman and CEO at Ascentage Pharma Group International. This profile follows SEC Form 4 activity through May 22, 2026, including 10 public disclosures. Recent filings connect the profile to Ascentage Pharma Group International (AAPG). The current snapshot covers public activity from May 22, 2026. Reported amounts are shown as $2.0M to $839.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.